ERAP2 and cancer: Similarly, using RNA-seq data, we found that a lower expression of APM-related genes, including B2M, CIITA, ERAP2, TAP2 and TAPBPL, was also associated with a shorter PFS, reflecting the increasing interest in APM biomarkers for clinical outcome and immune escape in cancer (40).